Guilherme Perboyre Cavalcanti Sells 183,501 Shares of JBS (NYSE:JBS) Stock

Jbs N.V. (NYSE:JBS) CFO Guilherme Perboyre Cavalcanti sold 183,501 shares of the business’s stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $13.85, for a total value of $2,541,488.85. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

JBS Stock Performance

Shares of JBS stock opened at $13.74 on Thursday. The company has a market cap of $10.66 billion, a price-to-earnings ratio of 13.47, a price-to-earnings-growth ratio of 5.24 and a beta of -1.65. Jbs N.V. has a 52 week low of $11.49 and a 52 week high of $18.65. The company has a quick ratio of 0.77, a current ratio of 1.53 and a debt-to-equity ratio of 2.51. The firm has a 50 day moving average of $12.81 and a 200-day moving average of $14.48.

JBS (NYSE:JBS) last released its quarterly earnings data on Monday, August 10th. The company reported $0.20 earnings per share for the quarter, missing the consensus estimate of $0.32 by ($0.12). The company had revenue of $23.90 billion during the quarter. JBS had a net margin of 1.22% and a return on equity of 12.00%. JBS’s revenue for the quarter was up 13.8% on a year-over-year basis. On average, equities analysts forecast that Jbs N.V. will post 1.08 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on JBS shares. JPMorgan Chase & Co. dropped their price objective on shares of JBS from $18.00 to $17.50 and set an “overweight” rating on the stock in a report on Wednesday, August 12th. Zacks Research upgraded JBS from a “strong sell” rating to a “hold” rating in a research note on Monday, July 13th. UBS Group boosted their target price on JBS from $17.00 to $17.50 and gave the company a “buy” rating in a research report on Monday. Barclays dropped their price target on JBS from $21.00 to $20.00 and set an “overweight” rating on the stock in a research note on Thursday, July 16th. Finally, Wall Street Zen lowered JBS from a “hold” rating to a “sell” rating in a report on Saturday, August 15th. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, JBS presently has a consensus rating of “Moderate Buy” and a consensus price target of $18.42.

Institutional Trading of JBS

Hedge funds and other institutional investors have recently bought and sold shares of the business. BNDES Participacoes S.A. acquired a new position in shares of JBS during the fourth quarter valued at about $2,874,074,000. Davis Selected Advisers acquired a new stake in shares of JBS in the 4th quarter worth about $170,945,000. Banco BTG Pactual S.A. acquired a new stake in shares of JBS in the 3rd quarter worth about $143,175,000. Ameriprise Financial Inc. raised its holdings in shares of JBS by 23,891.7% in the 3rd quarter. Ameriprise Financial Inc. now owns 6,583,073 shares of the company’s stock worth $98,285,000 after acquiring an additional 6,555,634 shares during the last quarter. Finally, State Street Corp bought a new position in JBS in the 2nd quarter valued at about $84,109,000.

About JBS

JBS SA is a global leader in the production and processing of meat products, with a focus on beef, pork and poultry. Headquartered in São Paulo, Brazil, the company operates through an extensive network of owned facilities and partnerships that span the Americas, Europe and the Asia-Pacific region. JBS supplies fresh, frozen and value-added protein solutions for retail, foodservice and industrial customers, and is active across the entire supply chain—from livestock procurement and feed production to slaughtering, processing, packaging and distribution.

Founded in 1953 by José Batista Sobrinho in Anápolis, Goiás, JBS began as a small slaughterhouse and expanded rapidly through strategic acquisitions and organic growth.